Crossmark

Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review

Published Online: 2021-04-15

Published Print: 2021-06

Authors

Gómez-Arias, Pedro Jesús

Gómez-García, Francisco

Hernández-Parada, Jorge

Montilla-López, Ana María

Ruano, Juan

Parra-Peralbo, Esmeralda
Funding

Funding for this research was provided by:

Consejería de Salud, Junta de Andalucía (PIN-0316-2017)
License Information

Text and Data Mining valid from 2021-04-15

Version of Record valid from 2021-04-15
More Information

Article History

Received: 12 February 2021

First Online: 15 April 2021

Document is current